Maya Thomas
Neurology · Murray, UTNPI 1730138629
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 172 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $941 and has fallen 95.8% since, to $40 in 2025.
Across 172 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Harmony Biosciences LLC$761
- Jazz Pharmaceuticals Inc.$649
- Teva Pharmaceuticals USA, Inc.$228
- UCB, Inc.$211
- AbbVie$187
- Vanda Pharmaceuticals Inc.$160
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,24593%
- Education$2407%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Harmony Biosciences LLC | 38 | $761 |
| Jazz Pharmaceuticals Inc. | 30 | $649 |
| Teva Pharmaceuticals USA, Inc. | 14 | $228 |
| UCB, Inc. | 9 | $211 |
| AbbVie | 10 | $187 |
| Vanda Pharmaceuticals Inc. | 8 | $160 |
| Philips North America LLC | 6 | $148 |
| Livanova USA, Inc. | 7 | $148 |
| Dexcom, Inc. | 2 | $130 |
| Supernus Pharmaceuticals, Inc. | 9 | $125 |
| Axsome Therapeutics, Inc. | 6 | $109 |
| Boston Scientific | 2 | $97 |
| Neurelis, Inc. | 5 | $86 |
| Lundbeck LLC | 3 | $51 |
| Idorsia Pharmaceuticals US Inc | 3 | $48 |
| Greenwich Biosciences, Inc. | 2 | $42 |
| Amgen | 2 | $39 |
| Resmed Corp | 2 | $35 |
| Biogen | 2 | $33 |
| Pfizer | 2 | $29 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $21 |
| Novartis | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| Sanofi | 1 | $19 |
| Alfasigma USA, Inc. | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Merck | 1 | $14 |
| Itamar Medical Inc | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,485 in reported general payments places this provider in the 65th percentile of 157 neurology providers in Utah.
Other neurology in Murray
- Nigel HarrisonMurray$41K
- Michael HunterMurray$33K
- Heston ArnoldMurray$20K
- Evan BlackMurray$15K
- Kathleen McKeeMurray$3K
- Timothy WestSalt Lake City$856K
- Richard HammondOgden$707K
- Jeffrey GrovesDraper$628K
- Stacey SteevesSalt Lake City$548K
- Amir ArainSalt Lake City$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.